cipla
-
Cipla launches Leuprolide Acetate Injection Depot 22.5mg
The injection is indicated for the palliative treatment of advanced prostate cancer Cipla has launched Leuprolide Acetate Injection Depot 22.5mg.…
Read More » -
Cipla bags US FDA approval for generic version of Revlimid
The drug is indicated for several haematological malignancies in adults such as Multiple Myeloma, Myelodysplastic syndromes, Mantle cell lymphoma, Follicular…
Read More » -
Cipla to invest more in digital tech company GoApptiv
To hold 22.02 per cent stake post completion of the proposed transaction Cipla has agreed to acquire an additional stake…
Read More » -
Cipla buys stake in Achira Labs
To develop affordable, innovative medical kits in India Cipla has signed definitive agreements for the acquisition of a 21.05 per…
Read More » -
Cipla launches ‘RT Direct’ real time PCR kit for COVID-19
RNA extraction free kit to deliver results in 45 mins Cipla announced the commercialisation of ‘RT-Direct’ multiplex COVID-19 RT PCR…
Read More » -
Cipla registers Q3 FY22 PAT of Rs 729 crore
The company registers an EBITDA of Rs 1243 crore Cipla announced its unaudited consolidated financial results for the quarter ended…
Read More » -
Cipla acquires stake in Clean Max Auriga Power
The agreement is in line with the company’s commitment to enhance the share of renewable power sources in its operation…
Read More »